ApoE e4e4 Genotype and Mortality With COVID-19 in UK Biobank
The ApoE e4e4 genotype was associated with COVID-19 test positivity (odds ratio [OR] = 2.31,95% CI: 1.65-3.24, p = 1.19 · 10"6) (1) in the UK Biobank (UKB) cohort, during the epidemic peak in England, from March 16 to April 26,2020. With more COVID-19 test results (March 16 to May 31,2020) and...
Saved in:
Published in: | The journals of gerontology. Series A, Biological sciences and medical sciences Vol. 75; no. 9; pp. 1801 - 1803 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
US
Oxford University Press
16-09-2020
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The ApoE e4e4 genotype was associated with COVID-19 test positivity (odds ratio [OR] = 2.31,95% CI: 1.65-3.24, p = 1.19 · 10"6) (1) in the UK Biobank (UKB) cohort, during the epidemic peak in England, from March 16 to April 26,2020. With more COVID-19 test results (March 16 to May 31,2020) and mortality data (to March 31,2020, with incomplete data for April 2020) linked to UKB, the ApoE e4 allele association with COVID-19 test positivity were reevaluated, and with all-cause mortality following test-confirmed COVID-19. Here, Kuo et al investigates the relation between the ApoE e4e4 genotype and mortality with COVID-19 in UK Biobank. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Commentary-1 |
ISSN: | 1079-5006 1758-535X |
DOI: | 10.1093/gerona/glaa169 |